Inventor
LIANG CONGXIN
US44 patents
⚠️ This page may combine multiple inventors who share the name “LIANG CONGXIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUGEN INC
17 patentsUS6573293B2Jun 3, 2003
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC174 citations98
US6653308B2Nov 25, 2003
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
SUGEN INC75 citations96
US6610688B2Aug 26, 2003
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
SUGEN INC74 citations96
US7125905B2Oct 24, 2006
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC59 citations95
US6777417B2Aug 17, 2004
3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors
SUGEN INC56 citations95
US7572924B2Aug 11, 2009
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC25 citations92
US7186832B2Mar 6, 2007
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
SUGEN INC32 citations92
US6689806B1Feb 10, 2004
Indolinone compounds as kinase inhibitors
SUGEN INC29 citations92
US6599902B2Jul 29, 2003
5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
SUGEN INC21 citations92
US6642232B2Nov 4, 2003
3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
SUGEN INC13 citations81
US6908930B2Jun 21, 2005
4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors
SUGEN INC6 citations74
US7157460B2Jan 2, 2007
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
SUGEN INC8 citations73
US6531502B1Mar 11, 2003
3-Methylidenyl-2-indolinone modulators of protein kinase
SUGEN INC10 citations70
US7157577B2Jan 2, 2007
5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
SUGEN INC6 citations60
US7582756B2Sep 1, 2009
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
SUGEN INC0 citations51
US6855730B2Feb 15, 2005
3-methylidenyl-2-indolinone modulators of protein kinase
SUGEN INC1 citations48
US7122548B2Oct 17, 2006
Triazolotriazine compounds and uses thereof
SUGEN INC0 citations40
LIANG CONGXIN
11 patentsUS8524709B2Sep 3, 2013
Kinase inhibitor compounds
LIANG CONGXIN42 citations93
US8586582B2Nov 19, 2013
PI3K/mTOR kinase inhibitors
LIANG CONGXIN14 citations84
US8569296B2Oct 29, 2013
PI3K (delta) selective inhibitors
LIANG CONGXIN11 citations84
US8513221B2Aug 20, 2013
PI3K isoform selective inhibitors
LIANG CONGXIN5 citations73
US8697866B2Apr 15, 2014
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
LIANG CONGXIN3 citations63
US8198276B2Jun 12, 2012
Kinase inhibitor compounds
LIANG CONGXIN2 citations62
US9242958B2Jan 26, 2016
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
LIANG CONGXIN1 citations52
US9126947B2Sep 8, 2015
Substituted pyridazine carboxamide compounds
LIANG CONGXIN1 citations52
US8912178B2Dec 16, 2014
mTOR selective kinase inhibitors
LIANG CONGXIN1 citations52
US8551995B2Oct 8, 2013
Kinase inhibitor compounds
LIANG CONGXIN1 citations52
US8501763B2Aug 6, 2013
Inhibitors of focal adhesion kinase
LIANG CONGXIN1 citations51
HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD
3 patentsUSRE49834EFeb 13, 2024
Jak1 selective inhibitors and uses thereof
HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD1 citations71
US12297206B2May 13, 2025
Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt
HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD1 citations56
US12195476B2Jan 14, 2025
Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof
HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD1 citations56
TYROGENEX INC
2 patentsEQUINOX SCIENCES LLC
2 patentsUS11053224B2Jul 6, 2021
Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof
EQUINOX SCIENCES LLC7 citations79
US12209080B2Jan 28, 2025
Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof
EQUINOX SCIENCES LLC0 citations57